Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
356.5 INR | -2.41% | +14.32% | +13.00% |
Business Summary
Number of employees: 1,628
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical and Related Products
100.0
%
| 7,792 | 100.0 % | 6,906 | 100.0 % | -11.36% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
India
84.5
%
| 7,070 | 90.7 % | 5,837 | 84.5 % | -17.44% |
Asia
7.4
%
| 281 | 3.6 % | 512 | 7.4 % | +81.92% |
Europe
4.3
%
| 255 | 3.3 % | 294 | 4.3 % | +15.29% |
Africa
1.9
%
| 91 | 1.2 % | 134 | 1.9 % | +47.58% |
North America
1.7
%
| 84 | 1.1 % | 116 | 1.7 % | +39.09% |
South America
0.1
%
| 6 | 0.1 % | 8 | 0.1 % | +20.12% |
Australia
0.1
%
| 4 | 0.1 % | 5 | 0.1 % | +31.86% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 41 | 04-06-24 | |
Chief Executive Officer | - | 99-08-30 | |
Director of Finance/CFO | - | 18-10-28 | |
Chief Operating Officer | - | 19-07-31 | |
Ami Naresh Shah
CMP | Compliance Officer | - | 16-03-21 |
Avik Das
IRC | Investor Relations Contact | - | - |
Sunil Desai
HRO | Human Resources Officer | - | - |
Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 99-08-30 | |
Chief Executive Officer | 41 | 04-06-24 | |
Director/Board Member | 65 | 86-12-31 | |
Director/Board Member | 61 | 14-09-25 | |
Gopal M. Daptari
BRD | Director/Board Member | 74 | 17-09-04 |
Balram H. Singh
BRD | Director/Board Member | 65 | 18-05-28 |
Director/Board Member | - | 19-06-28 | |
Director/Board Member | - | 19-12-22 | |
Dilip B. Ghosh
BRD | Director/Board Member | 71 | 20-11-11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 100,277,506 | 22,409,305 ( 22.35 %) | 0 | 22.35 % |
Company contact information
Sector
Sales per region
1st Jan change | Capi. | |
---|---|---|
+13.00% | 438M | |
+50.70% | 795B | |
+41.96% | 627B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 294B | |
+18.02% | 245B | |
+1.27% | 222B | |
+11.95% | 215B | |
+3.68% | 160B |
- Stock Market
- Equities
- GUFICBIO Stock
- Company Gufic Biosciences Limited